Established in 2003 in Geneva, Switzerland, DNDi’s headquarters office is active in Research & Development activities, as well as in fundraising, communications, and advocacy. The team manages projects and partnerships so that new and adapted treatments are developed for sleeping sickness, leishmaniasis, Chagas disease, paediatric HIV, filarial diseases, mycetoma, and hepatitis C. DNDi Geneva is also incubating the WHO-DNDi joint initiative ‘Global Antibiotic Research & Development Partnership (GARDP).
www.dndi.org



DNDi Geneva Office

15 Chemin Louis-Dunant
1202 Geneva
Switzerland

Tel: + 41 22 906 9230
Fax: +41 22 906 9231
Email: dndi@dndi.org